Palisade Bio Inc. (PALI)
NASDAQ: PALI
· Real-Time Price · USD
0.63
-0.00 (-0.43%)
At close: Sep 05, 2025, 3:59 PM
0.60
-3.62%
After-hours: Sep 05, 2025, 07:56 PM EDT
Palisade Bio Revenue Breakdown
| Period Ending | Mar 31, 2023 |
|---|---|
| License Revenue | 300 |
| License Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.17M | 1.36M | 1.3M | 1.46M | 1.58M | 1.46M | 1.56M | 1.67M | 1.43M | 1.54M | 1.5M | 2.08M | 2.25M | 2.93M | 3.23M | 2.39M | 2.43M | 1.26M | 2.46M | 1.4M | 1.19M | 1.3M | 1.37M | 1.3M | 971.82K | 944.6K | 928.44K | 1.19M | 1.26M | 1.18M | 1.3M | 1.21M | 1.64M | 1.33M | 1.64M | 1.33M | 1.36M | 3.17M | 1.6M | 1.81M | 1.68M | 1.43M |
| Selling, General, and Administrative Revenue Growth | -14.19% | +4.78% | -10.85% | -8.02% | +8.57% | -6.42% | -6.93% | +16.90% | -6.89% | +2.19% | -27.47% | -7.98% | -23.01% | -9.23% | +34.91% | -1.44% | +92.31% | -48.70% | +75.21% | +17.88% | -8.36% | -5.00% | +5.15% | +33.87% | +2.88% | +1.74% | -21.85% | -5.79% | +6.68% | -8.80% | +7.37% | -26.22% | +22.82% | -18.53% | +22.93% | -2.35% | -57.05% | +97.69% | -11.28% | +7.36% | +17.52% | n/a |
| Research and Development Revenue | 1.68M | 950K | 2.08M | 2.14M | 2.63M | 2.21M | 1.73M | 1.74M | 2.18M | 1.24M | 2.34M | 1.93M | 1.32M | 959K | 800K | 624K | 314K | 692K | 785K | 412K | 650K | 1.25M | 1.01M | 825.49K | 954.45K | 1.51M | 878.87K | 897.1K | 1.01M | 1.17M | 1.23M | 1.38M | 2.58M | 2.9M | 4.03M | 3.59M | 2.48M | 3.07M | 2.75M | 3.39M | 3.31M | 3.18M |
| Research and Development Revenue Growth | +76.32% | -54.41% | -2.48% | -18.68% | +18.70% | +27.76% | -0.52% | -19.98% | +75.42% | -47.03% | +21.52% | +46.39% | +37.33% | +19.88% | +28.21% | +98.73% | -54.62% | -11.85% | +90.53% | -36.62% | -48.04% | +23.74% | +22.47% | -13.51% | -36.96% | +72.27% | -2.03% | -11.62% | -13.17% | -4.57% | -11.49% | -46.46% | -10.92% | -27.92% | +12.14% | +45.05% | -19.28% | +11.49% | -18.93% | +2.38% | +4.08% | n/a |